Insider trading

Period: 120 months Stock: EL Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

125 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

125 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

125 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

125 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
125 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
125 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

125 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Aug 2026
La Lande Rashida Exec VP & General Counsel
Sold at will
$802.38K 7,766 at 103.32
100%
Sold half or more
21 Aug 2026
La Lande Rashida Exec VP & General Counsel
Sold at will
$553.90K 5,564 at 99.55
100%
Sold half or more
26 Nov 2025
La Lande Rashida Exec VP & General Counsel
Sold at will
$151.50K 1,604 at 94.45
100%
Sold half or more
18 Nov 2025
Webster Meridith Exec VP GlobalComm/PubAffairs
Sold at will
$476.97K 5,430 at 87.84
100%
Sold half or more
6 Nov 2025
LAL 2015 ELF Trust 10% owner
Sold at will
$508.60M 5,670,000 at 89.70
100%
Sold half or more
6 Nov 2025
Sold at will
$255.22M 2,845,283 at 89.70
100%
Sold half or more
6 Nov 2025
Sold at will
$249.91M 2,786,040 at 89.70
100%
Sold half or more
28 Aug 2025
La Lande Rashida Executive VP & General Counsel
Sold at will
$589.59K 6,417 at 91.88
100%
Sold half or more
14 Nov 2024
FRIBOURG PAUL J Director · indirect
Bought 2×
$5.04M 78,000 at 64.61
98.7%
Largest buy in 3 yrs
14 Nov 2024
Shrivastava Akhil EVP & CFO
Bought
$65.00K 1,000 at 65.00
147%
First buy on file
22 May 2024
JUEPTNER PETER Group President
Sold at will
$1.67M 12,786 at 130.62
69.6%
Sold half or more
7 Feb 2024
Hyman Jennifer Director
Bought
$198.05K 1,350 at 146.70
135%
First buy on file
11 May 2023
Hertzmark Hudis Jane Executive Group President
Sold at will 3×
$8.75M 43,311 at 202.09
67.1%
Sold half or more
13 Feb 2023
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$2.47M 9,741 at 253.90
67.1%
Sold half or more
3 Feb 2023
Hyman Jennifer Director
Sold, plan not stated 3×
$1.40M 5,234 at 266.88
84.0%
Sold half or more
9 Sep 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated 2×
$1.91M 7,559 at 252.05
69.6%
Sold half or more
7 Sep 2022
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$523.32K 2,118 at 247.08
100%
Sold half or more
11 Mar 2022
Freda Fabrizio President and CEO
Sold, plan not stated 7×
$34.13M 127,919 at 266.84
62.8%
Sold half or more
10 Feb 2022
LAUDER RONALD S Chairman, Clinique Labs, LLC
Sold, plan not stated
$214.96M 700,000 at 307.08
100%
Sold half or more
9 Feb 2022
Demsey John Group President
Sold, plan not stated
$3.21M 10,027 at 319.68
60.3%
Sold half or more
4 Feb 2022
Demsey John Group President
Sold, plan not stated 7×
$7.30M 23,248 at 314.10
77.9%
Sold half or more
4 Feb 2022
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$5.08M 16,389 at 309.88
100%
Sold half or more
2 Dec 2021
Lauder William P Executive Chairman
Sold, plan not stated 5×
$13.20M 40,141 at 328.94
100%
Sold half or more
1 Dec 2021
Lauder William P Executive Chairman
Sold, plan not stated 4×
$6.13M 18,579 at 329.70
82.3%
Sold half or more
17 Nov 2021
Sold, plan not stated
$684.46M 2,000,000 at 342.23
100%
Sold half or more
10 Nov 2021
Sold, plan not stated 4×
$16.43M 47,638 at 344.98
53.1%
Sold half or more
5 Nov 2021
MOSS SARA E Vice Chairman
Sold, plan not stated
$703.91K 2,035 at 345.90
100%
Sold half or more
3 Nov 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$656.94K 1,961 at 335.00
100%
Sold half or more
3 Sep 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$1.01M 2,947 at 343.18
100%
Sold half or more
2 Sep 2021
MOSS SARA E Vice Chairman
Sold, plan not stated 2×
$1.18M 3,451 at 342.56
100%
Sold half or more
25 Aug 2021
Sold, plan not stated 5×
$61.91M 184,293 at 335.95
100%
Sold half or more
20 Aug 2021
Demsey John Group President
Sold, plan not stated 2×
$2.13M 6,500 at 327.53
76.3%
Sold half or more
14 Jul 2021
Sold, plan not stated 2×
$17.40M 53,531 at 325.01
63.1%
Sold half or more
7 Jun 2021
Sold, plan not stated
$828.11K 2,740 at 302.23
100%
Sold half or more
27 May 2021
BRAVO ROSE MARIE Director
Sold, plan not stated
$1.29M 4,234 at 304.23
100%
Sold half or more
7 May 2021
Sold, plan not stated
$704.20K 2,329 at 302.36
100%
Sold half or more
5 May 2021
LAUDER RONALD S Chairman, Clinique Labs LLC
Sold, plan not stated
$496.40M 1,700,000 at 292.00
100%
Sold half or more
4 May 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated 2×
$643.10K 2,183 at 294.59
100%
Sold half or more
9 Apr 2021
MOSS SARA E Vice Chairman
Sold, plan not stated
$3.60M 12,000 at 300.00
100%
Sold half or more
8 Mar 2021
Sold, plan not stated
$564.38M 2,000,000 at 282.19
100%
Sold half or more
5 Mar 2021
BRAVO ROSE MARIE Director
Sold, plan not stated 7×
$1.16M 4,000 at 289.52
100%
Sold half or more
3 Mar 2021
LAUDER RONALD S Chairman, Clinique Labs LLC
Sold, plan not stated 5×
$82.17M 281,629 at 291.76
78.2%
Sold half or more
2 Mar 2021
LAUDER RONALD S Chairman, Clinique Labs LLC
Sold, plan not stated 3×
$22.77M 78,371 at 290.52
100%
Sold half or more
25 Feb 2021
MOSS SARA E Exec. VP, Gen. Counsel
Sold, plan not stated 2×
$5.11M 17,576 at 290.78
100%
Sold half or more
24 Feb 2021
Demsey John Group President
Sold, plan not stated 9×
$13.52M 45,895 at 294.65
80.6%
Sold half or more
24 Feb 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$5.61M 19,457 at 288.57
89.9%
Sold half or more
24 Feb 2021
Haney Carl P. EVP-Global R&D
Sold, plan not stated
$2.36M 8,000 at 295.49
56.4%
Sold half or more
24 Feb 2021
Sold, plan not stated
$886.65K 3,000 at 295.55
52.3%
Sold half or more
20 Nov 2020
Lauder William P Executive Chairman
Sold, plan not stated 2×
$1.93M 8,006 at 240.86
100%
Sold half or more
19 Nov 2020
Sold, plan not stated
$488.12M 2,000,000 at 244.06
100%
Sold half or more
Showing 1–50 of 125. Page 1 of 3 Older →